David P Turicek

发表

Efficacy of JAK1/2 and BCL2 inhibition on human T cell acute lymphoblastic leukemia in vitro and in vivo

L. Rui, M. Bouchlaka, C. Capitini, 2019, bioRxiv.

Inflammatory CD4/CD8 double positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology

N. Callander, S. McIlwain, M. Skala, 2022 .

Human CD4/CD8 double positive T cells are both predictive and sufficient to mediate

N. Callander, S. McIlwain, P. Hematti, 2022 .

Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology

N. Callander, S. McIlwain, M. Skala, 2022, bioRxiv.

Immune Effector Cell associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS).

Matthew J. Frigault, D. Teachey, M. Perales, 2023, Transplantation and cellular therapy.

CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma

Amy K. Erbe, C. Capitini, A. Erbe, 2023, bioRxiv.

Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology

N. Callander, S. McIlwain, M. Skala, 2023, bioRxiv.

CAR T-cell detection scoping review: an essential biomarker in critical need of standardization

N. Shah, Naomi Taylor, David P Turicek, 2023, Journal for ImmunoTherapy of Cancer.

CXCR4 allows T cell acute lymphoblastic leukemia to escape from JAK1/2 and BCL2 inhibition through CNS infiltration

L. Rui, C. Capitini, Monica M. Cho, 2021, Leukemia & lymphoma.